Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
Authors
Keywords
-
Journal
Expert Review of Clinical Pharmacology
Volume 11, Issue 9, Pages 889-902
Publisher
Informa UK Limited
Online
2018-08-13
DOI
10.1080/17512433.2018.1511424
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Psilocybin modulates functional connectivity of the amygdala during emotional face discrimination
- (2018) O. Grimm et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Serotonergic psychedelics and personality: A systematic review of contemporary research
- (2018) José Carlos Bouso et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review
- (2018) Simon Reiche et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
- (2018) Fernanda Palhano-Fontes et al. PSYCHOLOGICAL MEDICINE
- Psychedelics Promote Structural and Functional Neural Plasticity
- (2018) Calvin Ly et al. Cell Reports
- Altered network hub connectivity after acute LSD administration
- (2018) Felix Müller et al. NeuroImage-Clinical
- Psychiatry & the psychedelic drugs. Past, present & future
- (2017) James J.H. Rucker et al. NEUROPHARMACOLOGY
- Modern Clinical Research on LSD
- (2017) Matthias E Liechti NEUROPSYCHOPHARMACOLOGY
- The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future
- (2017) Robin L Carhart-Harris et al. NEUROPSYCHOPHARMACOLOGY
- Long-lasting subjective effects of LSD in normal subjects
- (2017) Yasmin Schmid et al. PSYCHOPHARMACOLOGY
- Acute effects of LSD on amygdala activity during processing of fearful stimuli in healthy subjects
- (2017) F Mueller et al. Translational Psychiatry
- The “Endless Trip” among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review
- (2017) Laura Orsolini et al. Frontiers in Psychiatry
- Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
- (2016) Anna Rickli et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Measuring the subjective: revisiting the psychometric properties of three rating scales that assess the acute effects of hallucinogens
- (2016) José Carlos Bouso et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression
- (2016) Rafael Faria Sanches et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging
- (2016) Rafael G dos Santos et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Decreased mental time travel to the past correlates with default-mode network disintegration under lysergic acid diethylamide
- (2016) Jana Speth et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
- (2016) Roland R Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial
- (2016) Stephen Ross et al. JOURNAL OF PSYCHOPHARMACOLOGY
- LSD Acutely Impairs Fear Recognition and Enhances Emotional Empathy and Sociality
- (2016) Patrick C Dolder et al. NEUROPSYCHOPHARMACOLOGY
- Classical hallucinogens and neuroimaging: A systematic review of human studies
- (2016) Rafael G. dos Santos et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Neural correlates of the LSD experience revealed by multimodal neuroimaging
- (2016) Robin L. Carhart-Harris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The paradoxical psychological effects of lysergic acid diethylamide (LSD)
- (2016) R. L. Carhart-Harris et al. PSYCHOLOGICAL MEDICINE
- Alterations of consciousness and mystical-type experiences after acute LSD in humans
- (2016) Matthias E. Liechti et al. PSYCHOPHARMACOLOGY
- Antidepressive and anxiolytic effects of ayahuasca: a systematic literature review of animal and human studies
- (2016) Rafael G. dos Santos et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- The mixed serotonin receptor agonist psilocybin reduces threat-induced modulation of amygdala connectivity
- (2016) Rainer Kraehenmann et al. NeuroImage-Clinical
- Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects
- (2015) Yasmin Schmid et al. BIOLOGICAL PSYCHIATRY
- Serotonergic Psychedelics Temporarily Modify Information Transfer in Humans
- (2015) Joan Francesc Alonso et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
- (2015) Michael P Bogenschutz et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
- (2015) Flávia de L. Osório et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- The Psychedelic State Induced by Ayahuasca Modulates the Activity and Connectivity of the Default Mode Network
- (2015) Fernanda Palhano-Fontes et al. PLoS One
- Metabolism and urinary disposition ofN,N-dimethyltryptamine after oral and smoked administration: a comparative study
- (2014) Jordi Riba et al. Drug Testing and Analysis
- Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases
- (2014) Peter Gasser et al. JOURNAL OF NERVOUS AND MENTAL DISEASE
- LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: A qualitative study of acute and sustained subjective effects
- (2014) Peter Gasser et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
- (2013) Harvey A Whiteford et al. LANCET
- Innovative solutions to novel drug development in mental health
- (2013) T.R. Insel et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users
- (2013) José Carlos Bouso et al. PSYCHOPHARMACOLOGY
- Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors
- (2012) Michael Kometer et al. BIOLOGICAL PSYCHIATRY
- Health status of ayahuasca users
- (2012) Paulo Cesar Ribeiro Barbosa et al. Drug Testing and Analysis
- 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects
- (2012) Fernando Caudevilla-Gálligo et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
- (2012) Teri S Krebs et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis
- (2012) Robin L. Carhart-Harris et al. SCHIZOPHRENIA BULLETIN
- Methodology in conducting a systematic review of systematic reviews of healthcare interventions
- (2011) Valerie Smith et al. BMC Medical Research Methodology
- Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness
- (2011) Katherine A MacLean et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
- (2011) Roland R. Griffiths et al. PSYCHOPHARMACOLOGY
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
- (2010) Charles S. Grob et al. ARCHIVES OF GENERAL PSYCHIATRY
- Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)
- (2010) Erich Studerus et al. PLoS One
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
- Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later
- (2008) RR Griffiths et al. JOURNAL OF PSYCHOPHARMACOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started